Biobank Market Size Worth USD 172.53 Billion in 2032 | Report Published by Emergen Research

The global Biobank market size was USD 76.31 Billion in 2022 and is expected to register a revenue CAGR of 8.8% during the forecast period. .This growth trajectory is attributed to key drivers such as the increasing funding in genomic research, rising demand for personalized medicine, and notable technological advancements within the sector.
Biobanks, which play a pivotal role in storing and managing biological samples and associated data, are classified into two main types: physical and virtual biobanks. Each type relies on specialized tools such as biobanking equipment and Laboratory Information Management Systems (LIMS) for efficient operation. These resources support various applications including therapeutic research, drug discovery, and clinical trials.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2868

One of the most significant advancements in the global biobank market is the growing use of big data and Artificial Intelligence (AI). Researchers are leveraging AI to uncover patterns within biobank data, aiding in the development of new treatments and drugs. Moreover, emerging technologies such as Blockchain, AI, and Organ-on-a-chip are reshaping biobanks, enhancing efficiency, quality, and development processes.

The increasing funding in genomic research acts as a catalyst for market growth, facilitating access to high-quality biological samples and detailed health data. This influx of funds drives the adoption of innovative technologies in biobanking, including automation and advanced sample processing, thereby fueling market expansion.
Furthermore, the rising demand for personalized medicine is a key driver propelling the global biobank market forward. Biobanks serve as critical resources for developing personalized medicine approaches by storing diverse biological samples and associated health data. This enables researchers to identify biomarkers and genetic variations linked to specific diseases, leading to the development of targeted therapies with enhanced efficacy and reduced side effects.

Technological advancements within biobanks, such as cloud-based platforms and automation systems, are also contributing significantly to market growth. These advancements enhance biobank efficiency and patient outcomes, further driving market expansion.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2868

Segment Insights

Segment-wise, the dominance of the physical biobank segment is attributed to the demand for high-quality samples, albeit with significant infrastructure investment. Conversely, the virtual biobank segment is expected to witness rapid growth due to lower infrastructure costs and increasing adoption of cloud-based solutions.

Products Insights :

In terms of products, the biobanking equipment segment holds the largest market share, driven by the demand for automated sample handling systems. Meanwhile, the Laboratory Information Management System (LIMS) segment is anticipated to experience the fastest growth, propelled by technological advancements and streamlined workflows.
The cell & tissue segment leads in sample types, driven by the therapeutic potential of stem cells. Application-wise, the therapeutic segment dominates due to the increasing prevalence of chronic diseases, while the clinical research segment exhibits rapid growth driven by translational research initiatives.

End-use Insights :
End-use analysis reveals the dominance of Pharma & Biotech companies, which heavily rely on biobank resources for drug discovery and development pipelines.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2868

Biobank Top Companies and Competitive Landscape
The global the global biobank market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Bio bank solutions.

Some major players included in the global the global biobank market report is:
• Merck KGaA
• QIAGEN
• Hamilton Company
• Thermo Fisher Scientific Inc
• Tecan Trading AG
• BD
• Taylor-Wharton
• Lonza
• STEMCELL Technologies
• Charles River Laboratories

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/biobank-market

For the purpose of this report, Emergen Research has segmented global biobank market on the basis of type, product, sample, application, end-use, and region:

• Type Outlook (Revenue, USD Billion; 2019-2032)
o Physical/ Real Biobanks
o Virtual Biobanks
• Product Outlook (Revenue, USD Billion; 2019-2032)
o Biobanking Equipment
o Laboratory Information Management System
• Sample Outlook (Revenue, USD Billion; 2019-2032)
o Blood
o Cell And Tissue
o Others
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Therapeutic
o Drug Discovery
o Clinical Research
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Pharma & Biotech Companies
o Academic Institute
o Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. U.K.
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of MEA

Emergen Research is Offering Exclusive Customization as per your Specific Requirements@ https://www.emergenresearch.com/request-for-customization/2868

Look Over transcripts provided by Emergen Research

Downstream Processing Market https://www.emergenresearch.com/industry-report/downstream-processing-market
Healthcare Cybersecurity Market https://www.emergenresearch.com/industry-report/healthcare-cybersecurity-market
Inhalation Anesthesia Market https://www.emergenresearch.com/industry-report/inhalation-anesthesia-market
Medication Management System Market https://www.emergenresearch.com/industry-report/medication-management-system-market
Sternal Closure System Market https://www.emergenresearch.com/industry-report/sternal-closure-system-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Trending Report: Cloud Computing Market RegTech Market

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.